Smooth muscle tumor of uncertain malignant potential
Uncommon uterine tumor with uncertain malignant potential.
George J Netto MD · CC BY-SA 4.0
Smooth muscle tumor of uncertain malignant potential, or STUMP, is a rare growth in the uterine smooth muscle that can act either benign or malignant. It is distinct from the prostatic stromal tumor of uncertain malignant potential, which shares the same abbreviation. To help classify these tumors and separate them from the main possibilities—leiomyosarcoma and uterine leiomyoma—the Bell criteria were created.
- Field
- Gynecologic pathology
- Known for
- Uterine smooth muscle tumor with uncertain malignant potential
- Differential diagnoses
- Leiomyosarcoma and uterine leiomyoma
Lore & Background
The Bell criteria provide a systematic approach to evaluating STUMP based on three key features: atypia, mitotic figures, and necrosis. Atypia is graded as none, minimal, moderate, or severe, with specific nuclear characteristics described for each level. Mitotic figure evaluation requires three criteria: hairy extensions of chromatin from a central dense mass, no nuclear membrane, and exclusion of lymphocytes, mast cells, stripped nuclei, degenerated cells, and precipitated hematoxylin. Counts are taken from 4 sets of 10 fields in the area of highest mitotic activity, using the highest count.
Reader's Guide
The Bell criteria algorithm guides classification: no or mild atypia with no tumor cell necrosis indicates leiomyoma; if 5 or more mitotic figures are present in 10 high powered fields but behavior appears benign, the diagnosis may append 'with significant mitotic activity.' Moderate to severe atypia without tumor cell necrosis is classified as atypical leiomyoma if fewer than 10 mitotic figures per high power field, or leiomyosarcoma if 10 or more. Moderate to severe atypia with tumor cell necrosis is always leiomyosarcoma, regardless of mitotic count. Coagulative tumor cell necrosis shows abrupt transition between necrotic and preserved cells with ghost nuclei but few inflammatory cells, while hyalinizing necrosis (more common in leiomyomas) features a zone of hyalinized collagen. Necrosis secondary to ulceration in submucous leiomyomas shows acute inflammatory cells and reparative changes. Bell's criteria do not apply to extrauterine tumors.
Did You Know?
- STUMP is an uncommon tumor of the uterine smooth muscle that may behave like a benign tumor or a cancerous tumor.
- The Bell criteria were developed to help categorize STUMP and differentiate it from leiomyosarcoma and uterine leiomyoma.
- Coagulative tumor cell necrosis in STUMP features an abrupt transition between necrotic cells and preserved cells, with ghost nuclei but few inflammatory cells.
Defining the Diagnostic Gray Zone
Smooth muscle tumor of uncertain malignant potential, commonly shortened to STUMP, represents one of the most diagnostically challenging entities in uterine pathology. This uncommon neoplasm arises from the smooth muscle of the uterus and occupies an uncomfortable middle ground: it may ultimately behave in a benign fashion or it may prove to be a cancerous growth. Because of this dual potential, pathologists must exercise particular care when rendering a diagnosis. It is worth noting that the abbreviation STUMP is shared by an entirely different entity—the prostatic stromal tumor of uncertain malignant potential—so context and anatomical site are essential to avoid confusion. The two principal conditions a pathologist must distinguish from STUMP are uterine leiomyoma, the familiar benign fibroid, and leiomyosarcoma, the aggressive malignant counterpart. The very name of the tumor acknowledges that, at the time of examination, the clinician cannot yet predict which of these trajectories the patient will follow, making careful histological assessment and long-term follow-up indispensable.
The Bell Criteria: Grading Cellular Atypia
To bring order to this diagnostic uncertainty, the Bell criteria were formulated as a structured framework for categorizing uterine smooth muscle tumors and separating them from their two main differential diagnoses. The first pillar of this system is the assessment of nuclear atypia, which is graded on a spectrum from absent to severe. When atypia is minimal, the pathologist observes smooth nuclear contours, little variation in nuclear size or shape, and evenly distributed chromatin. Moderate atypia introduces many large, plump, and irregular nuclei alongside one or two mitotic figures. At the severe end, the picture becomes alarming: obvious pleomorphism, enlarged and bizarre nuclei packed with dense chromatin, the presence of giant cells that are frequently multinucleated, and conspicuously enlarged atypical nucleoli. This graduated scale allows the examiner to place a tumor on a continuum rather than forcing a binary benign-versus-malignant call, and it sets the stage for the additional mitotic and necrotic evaluations that follow.
Counting Mitoses: A Delicate Microscopic Exercise
Evaluating mitotic figures in a STUMP is far from a simple tally. The Bell criteria demand that the examiner satisfy three specific conditions before a figure is counted as a true mitosis. First, there must be hairy extensions of chromatin radiating outward from a central, clot-like dense mass of chromosomes; if those hairy extensions emanate from an empty center instead, the structure likely represents a non-mitotic artifact. Second, the cell must lack a nuclear membrane. Third, the pathologist must actively exclude a list of mimics: lymphocytes, mast cells, stripped nuclei, degenerated cells, and even precipitated hematoxylin can all masquerade as mitotic figures under the microscope. Once these filters are applied, the counting protocol is precise: the examiner surveys four sets of ten high-powered fields within the region showing the greatest mitotic activity and records the highest count among them. This rigorous methodology exists because the mitotic index is a critical threshold that, together with atypia and necrosis, ultimately determines whether the tumor is classified as atypical leiomyoma, leiomyosarcoma, or something in between.
Necrosis Patterns and the Final Diagnostic Algorithm
The third component of the Bell criteria—necrosis—carries its own diagnostic weight, and the pattern of cell death helps the pathologist distinguish between entities. Coagulative tumor cell necrosis, characterized by an abrupt boundary between dead and preserved cells with ghost nuclei but few inflammatory infiltrates, is a hallmark of clinically malignant smooth muscle tumors. By contrast, hyalinizing necrosis, seen more often in benign leiomyomas, presents a zone of hyalinized, eosinophilic collagen separating dead from living cells, with any remaining nuclei appearing uniform. Ulceration-related necrosis in submucous leiomyomas is yet another pattern, marked by acute inflammatory cells and a peripheral reparative response while ghost nuclear outlines are faint or absent. The final algorithm then synthesizes all three findings: no or mild atypia without necrosis points to leiomyoma; moderate to severe atypia without necrosis yields atypical leiomyoma below ten mitotic figures or leiomyosarcoma at ten or more; and moderate to severe atypia combined with tumor cell necrosis mandates a leiomyosarcoma diagnosis regardless of mitotic count. Importantly, Bell's criteria are not applied to extrauterine tumors.
Gallery




Frequently Asked Questions
What exactly is Smooth muscle tumor of uncertain malignant potential?
STUMP is a rare growth arising from the smooth muscle of the uterus whose behavior can swing between benign and malignant, making its ultimate nature genuinely hard to pin down.
Why do pathologists find STUMP so frustrating to classify?
Because it sits in an awkward middle ground—it doesn't cleanly fit the profile of a straightforward uterine leiomyoma or a full-blown leiomyosarcoma, so its malignant potential stays uncertain even after examination.
How do doctors tell STUMP apart from leiomyosarcoma and uterine leiomyoma?
The Bell criteria were specifically developed as a set of histological thresholds to separate STUMP from those two main differential diagnoses, giving pathologists a structured way to call the tumor.
Is STUMP the same thing as the prostatic tumor that also goes by STUMP?
No—despite sharing the identical abbreviation, the smooth muscle tumor of uncertain malignant potential in the uterus and the prostatic stromal tumor of uncertain malignant potential are entirely separate entities in different organs.
Which branch of medicine is most associated with STUMP?
It falls squarely within gynecologic pathology, where specialists examine uterine tissue and work through the differential diagnoses that make this tumor so diagnostically tricky.
More in Types of cancer 1-21
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced
